0000899243-22-008088.txt : 20220228 0000899243-22-008088.hdr.sgml : 20220228 20220228163744 ACCESSION NUMBER: 0000899243-22-008088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220225 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee John Jui-Jen CENTRAL INDEX KEY: 0001844264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40030 FILM NUMBER: 22690426 MAIL ADDRESS: STREET 1: 1325 BOYLSTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Decibel Therapeutics, Inc. CENTRAL INDEX KEY: 0001656536 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464198709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1325 BOYLSTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: 617-370-8701 MAIL ADDRESS: STREET 1: 1325 BOYLSTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02215 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-25 0 0001656536 Decibel Therapeutics, Inc. DBTX 0001844264 Lee John Jui-Jen C/O DECIBEL THERAPEUTICS, INC. 1325 BOYLSTON STREET, SUITE 500 BOSTON MA 02215 0 1 0 0 Chief Development Officer Stock Options (right to buy) 3.50 2022-02-25 4 A 0 52500 0.00 A 2032-02-24 Common Stock 52500 52500 D The option was granted on February 25, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 25, 2023 and with respect to the remainder in 36 equal monthly installments thereafter through February 25, 2026. /s/ Elisabeth Leiderman, Attorney-in-Fact 2022-02-28